Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ASMB — Assembly Biosciences, Inc.

CIK 886982 NEW YORK, NY
Back to ASMB Full portfolio

Position in ASMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,787,650
+$2,782,962 QoQ
Shares Held
137,833
+280.7% QoQ
Ownership
0.677%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 92 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ASMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ASMB ranks #207 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ASMB

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,787,650 137,833
2026-03-31 $1,004,688 36,205
2025-12-31 $1,183,343 34,794
2025-09-30 $451,993 17,656
2022-12-31 $71,692 55,148
2022-09-30 $120,435 73,437
2022-06-30 $161,209 76,767
2022-03-31 $254,969 123,772
2021-12-31 $128,991 55,361
2021-09-30 $457,156 131,367
2021-06-30 $736,116 189,721
2021-03-31 $734,072 159,581
2020-12-31 $724,347 119,727
2020-09-30 $904,183 54,999
2020-06-30 $2,089,657 89,608
2020-03-31 $1,905,253 128,473